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May Supplement 200926S Poster Presentationsnumber of surgeries on patients age 80 with CI has increased, rate per
capita decreased by 14%, compared to a 20% decline in other age groups.
The incidence of significant comorbidities has substantially increased; for
claudicants: diabetes by 19%, HTP 30%, COPD 40%, CAD 21% and renal
230%; for patients with CI: HTP, COPD, and CAD incidence was higher
(23%, 32%, 8% respectively) but diabetics decreased by 6%. Cardiac, respira-
tory and infection complications after amputation have increased by 29%,
28% and 10%. For LER, respiratory complications increased 9% but cardiac
and infection complications actually decreased (8 and 27%) Similar trends
were observed for patients with combined LER and amputation. Length of
stay (LOS) declined significantly in all groups with an overall decrease of 30%
(p.05).
Conclusion: Despite the fact that patients, whether treated for claudi-
cation or CI, are sicker, older and havemore complications, the rate of major
amputations and LOS has significantly decreased due presumably to wide-
spread and successful use of endo LER and/or to earlier interventions driven
by the safety of endo LER.
Author Disclosures: R. Nowygrod, None; N.N. Egorova, None; S.
Guillerme, None; N. Morrissey, None; A.C. Gelijns, None; J.F. McKin-
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Purpose: To introduce an algorithm which has been successful in
minimizing complications related to the use of percutaneous closure devices.
Introduction: The following algorithm was implemented as follows:
Perclose was the default closure device used, except in cases where the artery
was very calcified or had dense scar tissue, in which case the Angioseal was
the first choice. If a Perclose failed, the Angioseal was attempted. If an
Angioseal failed, pressure was held for 15-30 minutes without peeking. If
holding pressure failed, a Femostop (Radi Medical) was applied.
Methods: The author made 201 punctures in 191 (103 male, 88
female) patients undergoing endovascular procedures from April 2006 to
October 2008. Risk factors included arrhythmia (n12, 6.28%), coronary
artery disease (n55, 28.80%), congestive heart failure (n9, 4.71%),
diabetes (n73, 38.22%), dialysis (n9, 4.71%), hyperlipidemia (n43,
22.51%), hypertension (n119, 62.30%), COPD (n13, 6.81%), history of
MI (n26, 13.61%), TIA/CVA (n7, 3.66%). ASA classifications were I
(n9, 4.71%), II (n35, 18.32%), III (n115, 60.21%) and IV (n23,
12.04%). Failure of the closure device was defined as persistent bleeding
requiring manual pressure, formation of a hematoma, blood transfusion, or
hospitalization. Failure of the algorithm was defined as formation of a
hematoma, blood transfusion or hospitalization.
Results: Perclose was selected as the first choice in 78.11% (n157) of
punctures and the Angioseal was selected in 17.80% (n44). The failure rate
for each device was 15.91% (n7) for Angioseal and 8.92% (n14) for
Perclose. The overall failure rate was 10.45%. All Angioseal failures were
successfully treated with manual compression. Perclose failures were ulti-
mately treated with an attempt at another closure device (n6), manual
compression (n6), or a Femostop (n2). Average recovery time was 1
hour 37 minutes (range: 23 minutes to 4 hours 48 minutes; SD: 39
minutes). 99.48% (n190) of patients were discharged same day; 0.52%
(n1) was admitted for thromboemboli. The final failure rate of the
algorithm was zero.
Conclusion: The described algorithm minimizes closure device-re-
lated complications. Implementation of this algorithm increases the safety of
performing endovascular interventions in an office angiosuite.
Author Disclosures: S.S. Ahn, Vascular Management Associates; J.F.
Chen, Vascular Management Associates; C. Kim, None; K. Peng, Vascular
Management Associates.
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Background: For patients with superficial femoral artery (SFA) occlu-
sive disease the most appropriate treatment has yet to be determined. We
performed a case control comparison of long term results of femoral popli-
teal bypass and SFA endovascular interventions to examine the characteris-
tics of patients and procedures to optimize results.Methods: All femoral-popliteal bypasses and SFA interventions per-
formed for consecutive patients with symptoms Rutherford 3 to 6 between
2001 and 2008 were reviewed. Kaplan Meir survival analyses were per-
formed to assess time-dependent outcomes. Log rank analyses, univariate
and multivariate analyses were performed.
Results: During the study period 152 limbs in 141 patients (66%male,
mean age 6622 years) underwent femoral-popliteal bypass; 233 limbs in
204 patients (49% male, mean age 70 11 years) underwent SFA interven-
tion. Surgery was performed less commonly for claudication (46% vs. 56%),
and more commonly for critical ischemia (54% vs 44%). Six year primary,
primary assisted and secondary patency rates were 56%, 64% and 75%
respectively for bypass patients. Six year primary, primary assisted and
secondary patency rates were 40%, 67% and 85% respectively for SFA
interventions. Six years limb salvage for surgery was 80%; six year limb
salvage rate was 92% for SFA interventions. Complications occurred in 21%
in the surgery group and in 1.2% of the endovascular group. Re-intervention
was required in 24% of surgery patients and in 14% of endovascular patients.
Failure of SFA intervention led to bypass in 5% of patients, however prior
failed intervention did not change target artery. Predictors of failed patency
for both the surgery and SFA intervention group were female gender,
diabetes, creatinine 1.8, and critical limb ischemia. However, limb salvage
was no different for all groups.
Conclusions: Though long term patency and limb salvage were equiv-
alent in this case controlled study of femoral popliteal bypass versus SFA
interventions, re-inventions and complications occurred at a higher rate in
the surgery group. Women, diabetics and renal failure patients had sustained
patency less frequently with both treatments; however, limb salvage was not
disadvantaged for any group. SFA stent placement should therefore be initial
therapy for patients with SFA occlusive disease.
Author Disclosures: E.M. Rzucidlo, None; A. Bjerke, None; D. Walsh,
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Background: In adult ICU, trauma, and surgical patients, blood
transfusion is associated with increased morbidity and mortality as well as
increased risk of venous /arterial thrombotic events and mortality in hospi-
talized cancer patients. We analyzed data from the NSQIP database to
examine the effect of intraoperative blood transfusion in patients undergo-
ing lower extremity revascularization( LER).
Methods: We queried the ACS NSQIP database from 2005 to 2007.
CPT codes were used to identify LER procedures which were grouped into
thromboendarterectomy(TEA), bypass with vein(BV) or prosthetic graft
(BP). Multivariable analysis adjusted transfusion impact for clinical risk
factors, procedure group and complexity.
Results:Our query resulted in 8799 patients, 66.8 12.0 years of age,
of whom5569 (63.3%) weremale. 12% underwent TEA, 42% underwent BP
and 46% underwent BV. Composite mortality was 2.9%, morbidity 25.5%.
Transfusion rates varied across procedure group from 14.5% in TEA pa-
tients, 20.1% in BV patients, to 27.1% in BP patients. Intraoperative trans-
fusion was associated with increased morbidity and mortality; after adjust-
ment for clinical risk factors, procedure type and complexity, transfusion
remained significantly predictive of poorer outcomes:
Table. 30-day outcomes for lower extremity
revascularization; patients transfused intraoperatively
versus not. Unadjusted rates and odds ratios adjusted for
all significant ACS NSQIP clinical risk factors, procedure
group and complexity
Outcome Not transfused Transfused P-value
Adjusted odds
ratio (95%
CI) P-value
N/ % 6827/77.6% 1971/22.4%
Mortality 1.9 6.2 .001 2.2 (1.6-2.9) .001
Morbidity 21.7 38.8 .001 1.7 (1.5-2.0) .001
Graft Failure 4.8 7.8 .001 1.4 (1.2-1.8) .001
Return to O.R. 15.4 26.8 .001 1.5 (1.3-1.7) .001
Wound Complication 10.5 14.4 .001 1.3 (1.1-1.6) .001
Sepsis/Shock 5.0 12.9 .001 1.9 (1.6-2.3) .001
Pulmonary Complication 3.5 14.5 .001 3.0 (2.5-3.7) .001
Renal Insuff./Failure 1.0 3.0 .001 1.9 (1.3-2.8) .002
